Regulatory Update

| 01 July 2011

On 27 May 2011, the Council of European Union (EU) adopted the Falsified Medicines Directive, which is meant to prevent falsified medicines from entering into the legal supply chain. The new directive includes substantive changes to Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) for active pharmaceutical ingredients (APIs) and excipients.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy